Schindellegi, Switzerland, July 5th, 2021
Zynnon is pleased to announce that it has joined the highly selective European InvestHorizon Accelerator. Launched in June 2019, the Investhorizon Accelerator has to date admitted 513 SMEs from 37 countries. In June 2021, Zynnon was selected along with another 74 deep tech start-ups and will join the accelerator programme for a period of four to six months.
Alex Marc, CFO of Zynnon is enthusiastic about this selection: “As a start-up, it is important to have a long-term vision, and it is particularly reassuring and motivating for the future to have our vision shared and recognised by such a prestigious organisation.”
InvestHorizon (https://investhorizon.eu) is a programme financed by the European Commission, in association with Eureka, to facilitate Series A funding for selected deep tech companies boosting their investment readiness and investor relations. The first 131 companies selected have already raised over EUR 53 million in equity funding.
The programme is run by a consortium coordinated by Tech Tour with six other partners: BPI France, Meta Group, EurA, BWCON, EBN, and IESE Business School.
Zynnon (www.zynnon.com) is a start-up focused on improving and protecting people’s health using the Internet of Medical Things (IoMT). Zynnon is developing Lieberty, an innovative non-contact multi-parametric sensor combining health and environmental parameters. It is used to analyse indoor spaces in order to evaluate the risk of respiratory infections. The hardware is used in conjunction with our cloud-based artificial intelligence solution, which generates an Infection Transmission Index and provides alerts as well as recommendations for corrective action.
This hardware and cloud solution provides key information for families, offering insights into older relatives’ living conditions, for example, so that they can make adjustments and act faster in the event of an alert. It helps older people to improve their health and safety in the home through the early detection of respiratory infection risks. This is also a valuable solution for care homes, where it can stop respiratory infections from spreading thanks to the early detection of risks in indoor spaces.
For further information:
CFO & Investor Relations Manager